Job Description

Grant Amount $300,000 USD

Grant Term3 Years

Start of Grant TermNovember 1, 2026

Letter of Intent DeadlineApril 14, 2026 1:00 PM (ET)

Letter of Intent Notification DateJune 2026

Application DeadlineAugust 4, 2026 1:00 PM (ET)

Decision DateOctober 2026

Additional InformationAdditional details regarding this grant program can be found in the Program Guidelines and Competitive Letter of Intent Instructions. Final determinations of eligibility will not be completed until the AACR is in receipt of the submitted Letter of Intent.

Description

The AACR-AstraZeneca Career Development Award for Physician-Scientists, in Honor of José Baselga was established to honor the life and legacy of Dr. José Baselga, who was a scientific leader and supportive mentor to an entire generation of physician-scientists. Dr. Baselga’s research focused on novel molecular targeted therapeutics and he played a leading role in the clinical development of multiple cancer drugs. The intent of this program is to encourage and support early-career physician-scientists to conduct research and bolster the development of innovative targeted therapeutics. The proposed projects may be translational, clinical, or population sciences in nature and focused on all aspects of oncology.

The grant provides $300,000 over a period of three years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborator, postdoctoral or clinical research fellows, graduate students (including tuition costs associated with graduate students’ education and training), or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses. Indirect costs are not permitted.